Proposed LCD DL40429: MolDX: Transcriptional Biomarkers for Therapeutic Decision-Making in Renal Carcinoma — Palmetto GBA
Policy LCD-DL40429 · Oncology
Proposed LCD: Molecular biomarkers for renal carcinoma tx decisions—comment by 1
Code intelligence
G0452 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code G0452.
Critical code riskView HCPCS detail
Signal breakdown
2 shown · 2 total in platform
Risk: Critical
1
Critical
50%
0
High
0%
1
Routine
50%
0
Low
0%
New this month
+1
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Critical
LCD L36951: MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™) — CGS
Policy LCD-L36951 · Oncology
New LCD could streamline billing for Oncotype DX tests in DCIS.
Audit documentation
Building an audit file that includes G0452?
The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Oncology audit pack — $349One-time purchase · not a subscription